nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—FGFR2—Thalidomide—leprosy	0.462	0.58	CbGbCtD
Regorafenib—UGT1A1—Rifampicin—leprosy	0.0922	0.116	CbGbCtD
Regorafenib—CYP2B6—Rifampicin—leprosy	0.0357	0.0448	CbGbCtD
Regorafenib—CYP2C8—Rifampicin—leprosy	0.027	0.0339	CbGbCtD
Regorafenib—CYP2C19—Thalidomide—leprosy	0.0234	0.0294	CbGbCtD
Regorafenib—CYP2C19—Rifampicin—leprosy	0.0227	0.0285	CbGbCtD
Regorafenib—CYP2C8—Dapsone—leprosy	0.0223	0.028	CbGbCtD
Regorafenib—CYP2C9—Thalidomide—leprosy	0.0195	0.0244	CbGbCtD
Regorafenib—CYP2C9—Rifampicin—leprosy	0.0188	0.0237	CbGbCtD
Regorafenib—CYP2C19—Dapsone—leprosy	0.0187	0.0235	CbGbCtD
Regorafenib—ABCB1—Rifampicin—leprosy	0.0183	0.023	CbGbCtD
Regorafenib—CYP2C9—Dapsone—leprosy	0.0156	0.0195	CbGbCtD
Regorafenib—CYP3A4—Rifampicin—leprosy	0.011	0.0138	CbGbCtD
Regorafenib—CYP3A4—Dapsone—leprosy	0.00905	0.0114	CbGbCtD
Regorafenib—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00739	0.105	CcSEcCtD
Regorafenib—DDR2—skin epidermis—leprosy	0.00636	0.0755	CbGeAlD
Regorafenib—Gastrointestinal perforation—Thalidomide—leprosy	0.00465	0.0662	CcSEcCtD
Regorafenib—Lipase increased—Thalidomide—leprosy	0.00413	0.0588	CcSEcCtD
Regorafenib—KDR—hindlimb—leprosy	0.00357	0.0423	CbGeAlD
Regorafenib—FGFR2—skin epidermis—leprosy	0.00325	0.0386	CbGeAlD
Regorafenib—KDR—appendage—leprosy	0.00306	0.0363	CbGeAlD
Regorafenib—Proteinuria—Dapsone—leprosy	0.0027	0.0384	CcSEcCtD
Regorafenib—Protein urine present—Dapsone—leprosy	0.00266	0.0379	CcSEcCtD
Regorafenib—FLT4—blood vessel—leprosy	0.00259	0.0308	CbGeAlD
Regorafenib—Lymphopenia—Thalidomide—leprosy	0.00237	0.0338	CcSEcCtD
Regorafenib—DDR2—eye—leprosy	0.00226	0.0269	CbGeAlD
Regorafenib—KIT—skin epidermis—leprosy	0.00226	0.0268	CbGeAlD
Regorafenib—EPHA2—blood vessel—leprosy	0.00214	0.0254	CbGeAlD
Regorafenib—TEK—blood vessel—leprosy	0.00208	0.0247	CbGeAlD
Regorafenib—FLT1—blood vessel—leprosy	0.00201	0.0239	CbGeAlD
Regorafenib—DDR2—skin of body—leprosy	0.00197	0.0234	CbGeAlD
Regorafenib—Hypomagnesaemia—Thalidomide—leprosy	0.00191	0.0272	CcSEcCtD
Regorafenib—Hypothyroidism—Thalidomide—leprosy	0.00189	0.0269	CcSEcCtD
Regorafenib—Nail disorder—Thalidomide—leprosy	0.00187	0.0266	CcSEcCtD
Regorafenib—KDR—blood vessel—leprosy	0.0017	0.0202	CbGeAlD
Regorafenib—NTRK1—testis—leprosy	0.00167	0.0198	CbGeAlD
Regorafenib—EPHX2—eye—leprosy	0.00153	0.0182	CbGeAlD
Regorafenib—Myocardial ischaemia—Thalidomide—leprosy	0.00151	0.0215	CcSEcCtD
Regorafenib—KIT—blood vessel—leprosy	0.00151	0.0179	CbGeAlD
Regorafenib—DDR2—tendon—leprosy	0.0015	0.0178	CbGeAlD
Regorafenib—PDGFRB—blood vessel—leprosy	0.00147	0.0175	CbGeAlD
Regorafenib—Endocrine disorder—Thalidomide—leprosy	0.00146	0.0208	CcSEcCtD
Regorafenib—FRK—testis—leprosy	0.00138	0.0164	CbGeAlD
Regorafenib—Proteinuria—Thalidomide—leprosy	0.00138	0.0197	CcSEcCtD
Regorafenib—FLT4—eye—leprosy	0.00138	0.0164	CbGeAlD
Regorafenib—Protein urine present—Thalidomide—leprosy	0.00136	0.0194	CcSEcCtD
Regorafenib—Musculoskeletal stiffness—Thalidomide—leprosy	0.00135	0.0193	CcSEcCtD
Regorafenib—Hyperbilirubinaemia—Thalidomide—leprosy	0.00133	0.019	CcSEcCtD
Regorafenib—Hypocalcaemia—Thalidomide—leprosy	0.00133	0.0189	CcSEcCtD
Regorafenib—Hyperuricaemia—Thalidomide—leprosy	0.00131	0.0186	CcSEcCtD
Regorafenib—DDR2—testis—leprosy	0.00124	0.0147	CbGeAlD
Regorafenib—Blood uric acid increased—Thalidomide—leprosy	0.00124	0.0176	CcSEcCtD
Regorafenib—DDR2—nervous system—leprosy	0.00122	0.0145	CbGeAlD
Regorafenib—MAPK11—testis—leprosy	0.00118	0.014	CbGeAlD
Regorafenib—FGFR2—eye—leprosy	0.00116	0.0137	CbGeAlD
Regorafenib—MAPK11—nervous system—leprosy	0.00115	0.0137	CbGeAlD
Regorafenib—FLT1—eye—leprosy	0.00107	0.0127	CbGeAlD
Regorafenib—RAF1—eye—leprosy	0.00107	0.0127	CbGeAlD
Regorafenib—BRAF—tendon—leprosy	0.00106	0.0126	CbGeAlD
Regorafenib—EPHX2—tendon—leprosy	0.00101	0.012	CbGeAlD
Regorafenib—FGFR2—skin of body—leprosy	0.00101	0.0119	CbGeAlD
Regorafenib—Gastroenteritis—Thalidomide—leprosy	0.000994	0.0141	CcSEcCtD
Regorafenib—RAF1—skin of body—leprosy	0.000927	0.011	CbGeAlD
Regorafenib—KDR—eye—leprosy	0.000906	0.0108	CbGeAlD
Regorafenib—FGFR1—tendon—leprosy	0.000901	0.0107	CbGeAlD
Regorafenib—Hyponatraemia—Thalidomide—leprosy	0.000884	0.0126	CcSEcCtD
Regorafenib—BRAF—testis—leprosy	0.000877	0.0104	CbGeAlD
Regorafenib—EPHX2—testis—leprosy	0.000838	0.00995	CbGeAlD
Regorafenib—Dry skin—Thalidomide—leprosy	0.000807	0.0115	CcSEcCtD
Regorafenib—RET—tendon—leprosy	0.000806	0.00957	CbGeAlD
Regorafenib—Hypokalaemia—Thalidomide—leprosy	0.000802	0.0114	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000793	0.0113	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000793	0.0113	CcSEcCtD
Regorafenib—PDGFRB—eye—leprosy	0.000784	0.00931	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Thalidomide—leprosy	0.000777	0.0111	CcSEcCtD
Regorafenib—FLT4—testis—leprosy	0.000756	0.00898	CbGeAlD
Regorafenib—EPHA2—tendon—leprosy	0.000753	0.00894	CbGeAlD
Regorafenib—FGFR1—testis—leprosy	0.000746	0.00886	CbGeAlD
Regorafenib—TEK—tendon—leprosy	0.000734	0.00872	CbGeAlD
Regorafenib—Neutropenia—Thalidomide—leprosy	0.000712	0.0101	CcSEcCtD
Regorafenib—FLT1—tendon—leprosy	0.00071	0.00843	CbGeAlD
Regorafenib—RAF1—tendon—leprosy	0.000706	0.00838	CbGeAlD
Regorafenib—ABL1—eye—leprosy	0.000699	0.0083	CbGeAlD
Regorafenib—KIT—skin of body—leprosy	0.000699	0.0083	CbGeAlD
Regorafenib—Gastrointestinal pain—Dapsone—leprosy	0.000692	0.00985	CcSEcCtD
Regorafenib—Weight decreased—Thalidomide—leprosy	0.000689	0.00981	CcSEcCtD
Regorafenib—PDGFRB—skin of body—leprosy	0.000682	0.0081	CbGeAlD
Regorafenib—Infestation—Thalidomide—leprosy	0.000679	0.00966	CcSEcCtD
Regorafenib—Infestation NOS—Thalidomide—leprosy	0.000679	0.00966	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000673	0.00958	CcSEcCtD
Regorafenib—Acute coronary syndrome—Thalidomide—leprosy	0.000669	0.00953	CcSEcCtD
Regorafenib—Body temperature increased—Dapsone—leprosy	0.000669	0.00952	CcSEcCtD
Regorafenib—Abdominal pain—Dapsone—leprosy	0.000669	0.00952	CcSEcCtD
Regorafenib—RET—testis—leprosy	0.000667	0.00793	CbGeAlD
Regorafenib—Myocardial infarction—Thalidomide—leprosy	0.000665	0.00947	CcSEcCtD
Regorafenib—PDGFRA—tendon—leprosy	0.000665	0.0079	CbGeAlD
Regorafenib—Stomatitis—Thalidomide—leprosy	0.000662	0.00942	CcSEcCtD
Regorafenib—RET—nervous system—leprosy	0.000655	0.00778	CbGeAlD
Regorafenib—FGFR2—testis—leprosy	0.000634	0.00753	CbGeAlD
Regorafenib—EPHA2—testis—leprosy	0.000623	0.0074	CbGeAlD
Regorafenib—FGFR2—nervous system—leprosy	0.000622	0.00739	CbGeAlD
Regorafenib—EPHA2—nervous system—leprosy	0.000612	0.00726	CbGeAlD
Regorafenib—ABL1—skin of body—leprosy	0.000608	0.00722	CbGeAlD
Regorafenib—TEK—testis—leprosy	0.000608	0.00722	CbGeAlD
Regorafenib—Urinary tract disorder—Thalidomide—leprosy	0.000602	0.00857	CcSEcCtD
Regorafenib—KDR—tendon—leprosy	0.0006	0.00713	CbGeAlD
Regorafenib—Urethral disorder—Thalidomide—leprosy	0.000597	0.0085	CcSEcCtD
Regorafenib—TEK—nervous system—leprosy	0.000597	0.00709	CbGeAlD
Regorafenib—FLT1—testis—leprosy	0.000588	0.00698	CbGeAlD
Regorafenib—RAF1—testis—leprosy	0.000584	0.00694	CbGeAlD
Regorafenib—FLT1—nervous system—leprosy	0.000577	0.00685	CbGeAlD
Regorafenib—Erythema multiforme—Thalidomide—leprosy	0.000576	0.0082	CcSEcCtD
Regorafenib—RAF1—nervous system—leprosy	0.000574	0.00681	CbGeAlD
Regorafenib—Cardiac disorder—Thalidomide—leprosy	0.000566	0.00805	CcSEcCtD
Regorafenib—Angiopathy—Thalidomide—leprosy	0.000553	0.00787	CcSEcCtD
Regorafenib—PDGFRA—testis—leprosy	0.000551	0.00654	CbGeAlD
Regorafenib—Mediastinal disorder—Thalidomide—leprosy	0.000549	0.00782	CcSEcCtD
Regorafenib—PDGFRA—nervous system—leprosy	0.000541	0.00642	CbGeAlD
Regorafenib—Alopecia—Thalidomide—leprosy	0.000539	0.00767	CcSEcCtD
Regorafenib—Vomiting—Dapsone—leprosy	0.000538	0.00766	CcSEcCtD
Regorafenib—Malnutrition—Thalidomide—leprosy	0.000531	0.00755	CcSEcCtD
Regorafenib—Headache—Dapsone—leprosy	0.00053	0.00754	CcSEcCtD
Regorafenib—PDGFRB—tendon—leprosy	0.000519	0.00617	CbGeAlD
Regorafenib—Nausea—Dapsone—leprosy	0.000502	0.00715	CcSEcCtD
Regorafenib—Tremor—Thalidomide—leprosy	0.000497	0.00708	CcSEcCtD
Regorafenib—KDR—testis—leprosy	0.000497	0.0059	CbGeAlD
Regorafenib—Anaemia—Thalidomide—leprosy	0.00049	0.00698	CcSEcCtD
Regorafenib—KDR—nervous system—leprosy	0.000488	0.00579	CbGeAlD
Regorafenib—Leukopenia—Thalidomide—leprosy	0.000475	0.00676	CcSEcCtD
Regorafenib—ABL1—tendon—leprosy	0.000463	0.0055	CbGeAlD
Regorafenib—Hypertension—Thalidomide—leprosy	0.000458	0.00652	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000449	0.00639	CcSEcCtD
Regorafenib—Dry mouth—Thalidomide—leprosy	0.000442	0.00629	CcSEcCtD
Regorafenib—KIT—testis—leprosy	0.00044	0.00523	CbGeAlD
Regorafenib—KIT—nervous system—leprosy	0.000432	0.00513	CbGeAlD
Regorafenib—Infection—Thalidomide—leprosy	0.00043	0.00612	CcSEcCtD
Regorafenib—PDGFRB—testis—leprosy	0.00043	0.00511	CbGeAlD
Regorafenib—Nervous system disorder—Thalidomide—leprosy	0.000425	0.00604	CcSEcCtD
Regorafenib—Thrombocytopenia—Thalidomide—leprosy	0.000424	0.00604	CcSEcCtD
Regorafenib—PDGFRB—nervous system—leprosy	0.000422	0.00501	CbGeAlD
Regorafenib—Skin disorder—Thalidomide—leprosy	0.000421	0.00599	CcSEcCtD
Regorafenib—ABCB1—blood vessel—leprosy	0.000409	0.00485	CbGeAlD
Regorafenib—ABL1—testis—leprosy	0.000383	0.00455	CbGeAlD
Regorafenib—Decreased appetite—Thalidomide—leprosy	0.000376	0.00536	CcSEcCtD
Regorafenib—ABL1—nervous system—leprosy	0.000376	0.00447	CbGeAlD
Regorafenib—Gastrointestinal disorder—Thalidomide—leprosy	0.000374	0.00532	CcSEcCtD
Regorafenib—Fatigue—Thalidomide—leprosy	0.000373	0.00531	CcSEcCtD
Regorafenib—Pain—Thalidomide—leprosy	0.00037	0.00527	CcSEcCtD
Regorafenib—Gastrointestinal pain—Thalidomide—leprosy	0.000354	0.00504	CcSEcCtD
Regorafenib—CYP2B6—skin of body—leprosy	0.000354	0.0042	CbGeAlD
Regorafenib—Abdominal pain—Thalidomide—leprosy	0.000342	0.00487	CcSEcCtD
Regorafenib—Body temperature increased—Thalidomide—leprosy	0.000342	0.00487	CcSEcCtD
Regorafenib—Asthenia—Thalidomide—leprosy	0.000311	0.00442	CcSEcCtD
Regorafenib—Diarrhoea—Thalidomide—leprosy	0.000296	0.00422	CcSEcCtD
Regorafenib—Vomiting—Thalidomide—leprosy	0.000275	0.00392	CcSEcCtD
Regorafenib—Rash—Thalidomide—leprosy	0.000273	0.00389	CcSEcCtD
Regorafenib—Dermatitis—Thalidomide—leprosy	0.000273	0.00388	CcSEcCtD
Regorafenib—Headache—Thalidomide—leprosy	0.000271	0.00386	CcSEcCtD
Regorafenib—Nausea—Thalidomide—leprosy	0.000257	0.00366	CcSEcCtD
Regorafenib—CYP2C8—testis—leprosy	0.000249	0.00295	CbGeAlD
Regorafenib—ABCG2—testis—leprosy	0.000242	0.00287	CbGeAlD
Regorafenib—CYP2B6—testis—leprosy	0.000223	0.00265	CbGeAlD
Regorafenib—CYP2B6—nervous system—leprosy	0.000219	0.0026	CbGeAlD
Regorafenib—CYP3A4—nervous system—leprosy	0.000165	0.00196	CbGeAlD
Regorafenib—ABCB1—testis—leprosy	0.000119	0.00142	CbGeAlD
Regorafenib—ABCB1—nervous system—leprosy	0.000117	0.00139	CbGeAlD
Regorafenib—ABCB1—Allograft Rejection—IL10—leprosy	0.000101	0.00205	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—CD40LG—leprosy	0.000101	0.00205	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—PARK2—leprosy	0.000101	0.00204	CbGpPWpGaD
Regorafenib—RAF1—Senescence and Autophagy in Cancer—IFNG—leprosy	0.000101	0.00204	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—RIPK2—leprosy	0.0001	0.00203	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CYLD—leprosy	9.95e-05	0.00202	CbGpPWpGaD
Regorafenib—RAF1—Corticotropin-releasing hormone—IL2—leprosy	9.94e-05	0.00201	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—PARK2—leprosy	9.9e-05	0.00201	CbGpPWpGaD
Regorafenib—MAPK11—Toll-like Receptor Signaling Pathway—TNF—leprosy	9.73e-05	0.00197	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CYLD—leprosy	9.7e-05	0.00196	CbGpPWpGaD
Regorafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—leprosy	9.45e-05	0.00191	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—PARK2—leprosy	9.4e-05	0.0019	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—PARK2—leprosy	9.37e-05	0.0019	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—NOD2—leprosy	9.24e-05	0.00187	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CYLD—leprosy	8.87e-05	0.0018	CbGpPWpGaD
Regorafenib—RAF1—Signaling by Interleukins—IL2—leprosy	8.74e-05	0.00177	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—PARK2—leprosy	8.45e-05	0.00171	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—RIPK2—leprosy	8.34e-05	0.00169	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—TLR2—leprosy	8.34e-05	0.00169	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	8.16e-05	0.00165	CbGpPWpGaD
Regorafenib—NTRK1—MAPK Signaling Pathway—TNF—leprosy	8.03e-05	0.00163	CbGpPWpGaD
Regorafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	7.79e-05	0.00158	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—TLR2—leprosy	7.65e-05	0.00155	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—RIPK2—leprosy	7.65e-05	0.00155	CbGpPWpGaD
Regorafenib—MAPK11—Regulation of toll-like receptor signaling pathway—TNF—leprosy	7.59e-05	0.00154	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—NOD2—leprosy	7.56e-05	0.00153	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC11A1—leprosy	7.54e-05	0.00153	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CYLD—leprosy	7.54e-05	0.00153	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—PARK2—leprosy	7.53e-05	0.00152	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—RIPK2—leprosy	7.52e-05	0.00152	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—TLR2—leprosy	7.52e-05	0.00152	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—RIPK2—leprosy	7.36e-05	0.00149	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—RIPK2—leprosy	7.35e-05	0.00149	CbGpPWpGaD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	7.25e-05	0.00147	CbGpPWpGaD
Regorafenib—RAF1—TNF alpha Signaling Pathway—TNF—leprosy	7.24e-05	0.00147	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—RIPK2—leprosy	7.22e-05	0.00146	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—IL2—leprosy	7.2e-05	0.00146	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—RIPK2—leprosy	7.13e-05	0.00145	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—TLR2—leprosy	7.13e-05	0.00145	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—RIPK2—leprosy	7.12e-05	0.00144	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—TLR2—leprosy	7.12e-05	0.00144	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—NOD2—leprosy	6.94e-05	0.00141	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CYLD—leprosy	6.92e-05	0.0014	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—RIPK2—leprosy	6.85e-05	0.00139	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—RIPK2—leprosy	6.83e-05	0.00138	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—NOD2—leprosy	6.82e-05	0.00138	CbGpPWpGaD
Regorafenib—KIT—Immune System—CYLD—leprosy	6.79e-05	0.00138	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PARK2—leprosy	6.66e-05	0.00135	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	6.57e-05	0.00133	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—NOD2—leprosy	6.47e-05	0.00131	CbGpPWpGaD
Regorafenib—BRAF—MAPK Signaling Pathway—TNF—leprosy	6.47e-05	0.00131	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—NOD2—leprosy	6.45e-05	0.00131	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CYLD—leprosy	6.45e-05	0.00131	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CYLD—leprosy	6.43e-05	0.0013	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—RIPK2—leprosy	6.41e-05	0.0013	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—TLR2—leprosy	6.41e-05	0.0013	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	6.29e-05	0.00127	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—RIPK2—leprosy	6.25e-05	0.00127	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—TLR2—leprosy	6.25e-05	0.00127	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—RIPK2—leprosy	6.16e-05	0.00125	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PARK2—leprosy	6.12e-05	0.00124	CbGpPWpGaD
Regorafenib—BRAF—Disease—SLC11A1—leprosy	6.09e-05	0.00123	CbGpPWpGaD
Regorafenib—KIT—Immune System—PARK2—leprosy	6.01e-05	0.00122	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—IFNG—leprosy	5.96e-05	0.00121	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—NOD2—leprosy	5.81e-05	0.00118	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CYLD—leprosy	5.79e-05	0.00117	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—RIPK2—leprosy	5.71e-05	0.00116	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—TLR2—leprosy	5.71e-05	0.00116	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PARK2—leprosy	5.7e-05	0.00115	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PARK2—leprosy	5.69e-05	0.00115	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—NOD2—leprosy	5.66e-05	0.00115	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CYLD—leprosy	5.65e-05	0.00114	CbGpPWpGaD
Regorafenib—FGFR2—Disease—SLC11A1—leprosy	5.65e-05	0.00114	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CD40LG—leprosy	5.63e-05	0.00114	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—TNF—leprosy	5.58e-05	0.00113	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CD8A—leprosy	5.57e-05	0.00113	CbGpPWpGaD
Regorafenib—KIT—Disease—SLC11A1—leprosy	5.55e-05	0.00112	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CD40LG—leprosy	5.53e-05	0.00112	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—RIPK2—leprosy	5.49e-05	0.00111	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—RIPK2—leprosy	5.49e-05	0.00111	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CD8A—leprosy	5.47e-05	0.00111	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—IL2—leprosy	5.3e-05	0.00107	CbGpPWpGaD
Regorafenib—FGFR1—Disease—SLC11A1—leprosy	5.26e-05	0.00107	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CD40LG—leprosy	5.25e-05	0.00106	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—SLC11A1—leprosy	5.25e-05	0.00106	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CD40LG—leprosy	5.24e-05	0.00106	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CD8A—leprosy	5.19e-05	0.00105	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—NOD2—leprosy	5.18e-05	0.00105	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CD8A—leprosy	5.18e-05	0.00105	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CYLD—leprosy	5.16e-05	0.00105	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PARK2—leprosy	5.12e-05	0.00104	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	5.04e-05	0.00102	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—leprosy	5.03e-05	0.00102	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TNF—leprosy	5.02e-05	0.00102	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PARK2—leprosy	4.99e-05	0.00101	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—IL2—leprosy	4.93e-05	0.000999	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—RIPK2—leprosy	4.86e-05	0.000984	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—TLR2—leprosy	4.86e-05	0.000984	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—SDHD—leprosy	4.83e-05	0.000978	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—SDHD—leprosy	4.83e-05	0.000978	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—SLC11A1—leprosy	4.73e-05	0.000958	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD40LG—leprosy	4.72e-05	0.000956	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD8A—leprosy	4.67e-05	0.000945	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—IFNG—leprosy	4.59e-05	0.00093	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PARK2—leprosy	4.57e-05	0.000925	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—TNF—leprosy	4.55e-05	0.000921	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—HLA-DRB1—leprosy	4.54e-05	0.000919	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TNF—leprosy	4.47e-05	0.000906	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—RIPK2—leprosy	4.46e-05	0.000903	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—TLR2—leprosy	4.46e-05	0.000903	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—HLA-DRB1—leprosy	4.45e-05	0.000902	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.41e-05	0.000894	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—NOD2—leprosy	4.4e-05	0.000892	CbGpPWpGaD
Regorafenib—KIT—Immune System—RIPK2—leprosy	4.38e-05	0.000887	CbGpPWpGaD
Regorafenib—KIT—Immune System—TLR2—leprosy	4.38e-05	0.000887	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—HLA-DRB1—leprosy	4.23e-05	0.000856	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—HLA-DRB1—leprosy	4.22e-05	0.000854	CbGpPWpGaD
Regorafenib—RAF1—Disease—SLC11A1—leprosy	4.22e-05	0.000854	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD40LG—leprosy	4.21e-05	0.000852	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD8A—leprosy	4.16e-05	0.000842	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—RIPK2—leprosy	4.16e-05	0.000842	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—TLR2—leprosy	4.16e-05	0.000842	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—RIPK2—leprosy	4.14e-05	0.00084	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—TLR2—leprosy	4.14e-05	0.00084	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—SDHD—leprosy	4.1e-05	0.00083	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—IL2—leprosy	4.08e-05	0.000827	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NOD2—leprosy	4.04e-05	0.000819	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.04e-05	0.000818	CbGpPWpGaD
Regorafenib—KIT—Immune System—NOD2—leprosy	3.97e-05	0.000804	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—RIPK2—leprosy	3.86e-05	0.000783	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—TNF—leprosy	3.86e-05	0.000781	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—HLA-DRB1—leprosy	3.8e-05	0.00077	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NOD2—leprosy	3.77e-05	0.000763	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NOD2—leprosy	3.76e-05	0.000761	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—TLR2—leprosy	3.73e-05	0.000756	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—RIPK2—leprosy	3.73e-05	0.000756	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD40LG—leprosy	3.72e-05	0.000754	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD8A—leprosy	3.68e-05	0.000745	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—RIPK2—leprosy	3.65e-05	0.00074	CbGpPWpGaD
Regorafenib—ABL1—Immune System—RIPK2—leprosy	3.64e-05	0.000737	CbGpPWpGaD
Regorafenib—ABL1—Immune System—TLR2—leprosy	3.64e-05	0.000737	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—CD4—leprosy	3.63e-05	0.000735	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	3.55e-05	0.00072	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD40LG—leprosy	3.42e-05	0.000692	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HLA-DRB1—leprosy	3.39e-05	0.000686	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NOD2—leprosy	3.39e-05	0.000686	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD8A—leprosy	3.38e-05	0.000684	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD40LG—leprosy	3.36e-05	0.00068	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—CD4—leprosy	3.33e-05	0.000675	CbGpPWpGaD
Regorafenib—RAF1—Immune System—TLR2—leprosy	3.33e-05	0.000674	CbGpPWpGaD
Regorafenib—RAF1—Immune System—RIPK2—leprosy	3.33e-05	0.000674	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD8A—leprosy	3.32e-05	0.000672	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NOD2—leprosy	3.3e-05	0.000668	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—CD4—leprosy	3.27e-05	0.000663	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—TNF—leprosy	3.2e-05	0.000649	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CD4—leprosy	3.2e-05	0.000648	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD40LG—leprosy	3.18e-05	0.000645	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD40LG—leprosy	3.18e-05	0.000643	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD8A—leprosy	3.15e-05	0.000638	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CD4—leprosy	3.14e-05	0.000636	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD8A—leprosy	3.14e-05	0.000636	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—RIPK2—leprosy	3.14e-05	0.000636	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—RIPK2—leprosy	3.11e-05	0.00063	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CD4—leprosy	3.11e-05	0.000629	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CD4—leprosy	3.1e-05	0.000627	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NOD2—leprosy	3.02e-05	0.000611	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SDHD—leprosy	3e-05	0.000608	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HLA-DRB1—leprosy	3e-05	0.000607	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CD4—leprosy	2.98e-05	0.000604	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CD4—leprosy	2.97e-05	0.000603	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IL2—leprosy	2.95e-05	0.000597	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—RIPK2—leprosy	2.88e-05	0.000584	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD40LG—leprosy	2.86e-05	0.00058	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—RIPK2—leprosy	2.83e-05	0.000573	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD8A—leprosy	2.83e-05	0.000573	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CD4—leprosy	2.79e-05	0.000565	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD40LG—leprosy	2.79e-05	0.000565	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—IL2—leprosy	2.78e-05	0.000563	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD8A—leprosy	2.76e-05	0.000559	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TNF—leprosy	2.75e-05	0.000558	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HLA-DRB1—leprosy	2.75e-05	0.000557	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CD4—leprosy	2.72e-05	0.000551	CbGpPWpGaD
Regorafenib—KIT—Immune System—HLA-DRB1—leprosy	2.7e-05	0.000547	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RIPK2—leprosy	2.69e-05	0.000544	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RIPK2—leprosy	2.68e-05	0.000543	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD4—leprosy	2.68e-05	0.000543	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-DRB1—leprosy	2.56e-05	0.000519	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-DRB1—leprosy	2.56e-05	0.000518	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD40LG—leprosy	2.55e-05	0.000517	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SDHD—leprosy	2.54e-05	0.000515	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—IL2—leprosy	2.54e-05	0.000515	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD8A—leprosy	2.52e-05	0.000511	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CD4—leprosy	2.49e-05	0.000504	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RIPK2—leprosy	2.41e-05	0.000489	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD4—leprosy	2.39e-05	0.000484	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—leprosy	2.36e-05	0.000477	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-DRB1—leprosy	2.3e-05	0.000467	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SDHD—leprosy	2.27e-05	0.00046	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-DRB1—leprosy	2.25e-05	0.000455	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SDHD—leprosy	2.21e-05	0.000449	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL2—leprosy	2.2e-05	0.000445	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IFNG—leprosy	2.19e-05	0.000443	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RIPK2—leprosy	2.15e-05	0.000436	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD4—leprosy	2.11e-05	0.000428	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SDHD—leprosy	2.07e-05	0.000419	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—leprosy	2.06e-05	0.000418	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-DRB1—leprosy	2.05e-05	0.000416	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IFNG—leprosy	2.01e-05	0.000407	CbGpPWpGaD
Regorafenib—KIT—Immune System—IFNG—leprosy	1.97e-05	0.0004	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL2—leprosy	1.94e-05	0.000394	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD4—leprosy	1.94e-05	0.000393	CbGpPWpGaD
Regorafenib—BRAF—Disease—CD4—leprosy	1.93e-05	0.000392	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD4—leprosy	1.91e-05	0.000386	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.9e-05	0.000386	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—leprosy	1.89e-05	0.000382	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IFNG—leprosy	1.87e-05	0.000379	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IFNG—leprosy	1.87e-05	0.000378	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD4—leprosy	1.81e-05	0.000366	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD4—leprosy	1.8e-05	0.000365	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CD4—leprosy	1.79e-05	0.000363	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL2—leprosy	1.79e-05	0.000362	CbGpPWpGaD
Regorafenib—KIT—Disease—CD4—leprosy	1.76e-05	0.000356	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL2—leprosy	1.75e-05	0.000355	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IFNG—leprosy	1.68e-05	0.000341	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CD4—leprosy	1.67e-05	0.000338	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CD4—leprosy	1.67e-05	0.000337	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL2—leprosy	1.66e-05	0.000337	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL2—leprosy	1.66e-05	0.000336	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IFNG—leprosy	1.64e-05	0.000332	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD4—leprosy	1.63e-05	0.000329	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—leprosy	1.58e-05	0.000321	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL2—leprosy	1.55e-05	0.000313	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—leprosy	1.5e-05	0.000304	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—leprosy	1.5e-05	0.000304	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—leprosy	1.5e-05	0.000303	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—leprosy	1.46e-05	0.000296	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—leprosy	1.46e-05	0.000296	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—leprosy	1.46e-05	0.000295	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—leprosy	1.45e-05	0.000293	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SDHD—leprosy	1.36e-05	0.000276	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—leprosy	1.34e-05	0.000271	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—leprosy	1.33e-05	0.00027	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—leprosy	1.26e-05	0.000255	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—leprosy	1.25e-05	0.000252	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—leprosy	1.15e-05	0.000234	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—leprosy	1.13e-05	0.00023	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—leprosy	1.08e-05	0.000218	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—leprosy	1.07e-05	0.000217	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—leprosy	9.67e-06	0.000196	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—leprosy	8.62e-06	0.000175	CbGpPWpGaD
